Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Frontiers in Physiology
|
November 19, 2019
MiR-29 Regulates <i>de novo</i> Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner
Yu-Han Hung, Matt Kanke, Catherine Lisa Kurtz, et al.
Physiological Genomics
|
June 29, 2019
Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice
Yu-Han Hung, Matt Kanke, C Lisa Kurtz, et al.
Journal of Lipid Research
|
February 7, 2019
Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference
Andrew A Butler, Candice A Price, James L Graham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 9, 2023
Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis
Henry J Taylor, Yu-Han Hung, Narisu Narisu, et al.
Journal of Neuroinflammation
|
February 25, 2023
Chronic kidney disease promotes cerebral microhemorrhage formation
Chuo Fang, Wei Ling Lau, Jiahong Sun, et al.
Journal of Neuroinflammation
|
March 5, 2025
Development of cerebral microhemorrhages in a mouse model of hypertension
Danny F Xie, Chuo Fang, Christian Crouzet, et al.
Communications Biology
|
August 27, 2024
miR-29 is an important driver of aging-related phenotypes
Vijay Swahari, Ayumi Nakamura, Emilie Hollville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2026
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
January 29, 2016
Patient assessment of diabetes care in a pay-for-performance program
Herng-Chia Chiu, Hui-Min Hsieh, Yi-Chieh Lin, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Frontiers in Physiology
|
November 19, 2019
MiR-29 Regulates <i>de novo</i> Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner
Yu-Han Hung, Matt Kanke, Catherine Lisa Kurtz, et al.
Physiological Genomics
|
June 29, 2019
Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice
Yu-Han Hung, Matt Kanke, C Lisa Kurtz, et al.
Journal of Lipid Research
|
February 7, 2019
Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference
Andrew A Butler, Candice A Price, James L Graham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 9, 2023
Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis
Henry J Taylor, Yu-Han Hung, Narisu Narisu, et al.
Journal of Neuroinflammation
|
February 25, 2023
Chronic kidney disease promotes cerebral microhemorrhage formation
Chuo Fang, Wei Ling Lau, Jiahong Sun, et al.
Journal of Neuroinflammation
|
March 5, 2025
Development of cerebral microhemorrhages in a mouse model of hypertension
Danny F Xie, Chuo Fang, Christian Crouzet, et al.
Communications Biology
|
August 27, 2024
miR-29 is an important driver of aging-related phenotypes
Vijay Swahari, Ayumi Nakamura, Emilie Hollville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2026
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
January 29, 2016
Patient assessment of diabetes care in a pay-for-performance program
Herng-Chia Chiu, Hui-Min Hsieh, Yi-Chieh Lin, et al.
Page
of 6